Fatigue independently associated with disease activity in SLE Dr.Niharika Harsha B25 Sept 2022 7:30 PM ISTA recent study found that Fatigue and disease activity are independent factors as found using the Physician Global Assessment (PGA). The study was...
JAMA study reports drug-induced lupus erythematosus in users of proton pump inhibitors Medha Baranwal23 Sept 2022 8:30 PM ISTFrance: In case of suspected cases of drug-induced lupus erythematosus (DILE), proton pump inhibitors (PPIs) should be considered as a potential...
Non-segmental vitiligo closely related to ocular problems: Study Dr. Kamal Kant Kohli23 Sept 2022 11:15 AM ISTEgypt: Ocular alterations are more likely to occur in those with non-segmental vitiligo states a study published in the Australasian Journal of...
Parkinson's disease modeling by Aged neurons from skin Isra Zaman23 Sept 2022 11:00 AM ISTAccording to a recent report from Janelle Drouin-Ouellet, Malin Parmar and colleagues in the one way of preserving the aged characteristics of neurons...
Dupilumab significantly improves skin lesions and itching among treated patients with prurigo nodularis Dr. Kamal Kant Kohli21 Sept 2022 8:00 PM ISTDupilumab improves skin lesions and itching among treated patients with prurigo nodularis, reveals Initrial data presented at the European Academy of...
Use of Benzoyl peroxide with microencapsulated tretinoin may improve acne lesions Jacinthlyn Sylvia20 Sept 2022 10:00 PM ISTUSA: In a new study published in SKIN-The Journal of Cutaneous Medicine, it was found that over a 12-week period, encapsulated benzoyl peroxide (BPO)...
Oral cyclosporine effective drug in decreasing episodes and intensity of cholinergic itch Dr Manoj Kumar Nayak20 Sept 2022 8:00 PM ISTCyclosporine effective in cholinergic itch- IDOJCholinergic itch is a part of the symptom complex which includes cholinergic erythema and cholinergic...
Secukinumab effective for treating pityriasis rubra pilaris: Study Jacinthlyn Sylvia19 Sept 2022 8:00 PM ISTUSA: Secukinumab is a good therapy with favorable outcomes for pityriasis rubra pilaris (PRP) and deserves more research, suggests an article...
Rituximab efficacious in chronic bullous disease of childhood: IDOJ Dr Manoj Kumar Nayak18 Sept 2022 7:30 PM ISTRituximab efficacious in chronic bullous disease of childhood: IDOJ Linear IgA disease (LAD) also known as chronic bullous disease of childhood...
No risk of VTE in Eczema Patients Receiving JAK Inhibitors: Study Dr. Shravani Dali17 Sept 2022 10:00 AM ISTThere is no risk for venous thromboembolism in Eczema Patients Receiving JAK Inhibitors suggests a new study published in the JAMA Dermatology. ...
Infants, young children finally get relief from eczema's terrible itch Isra Zaman17 Sept 2022 9:30 AM ISTThe first study to treat moderate-to-severe eczema in infants and children 6 months to 5 years old with a biologic drug rather than...
FDA Approves Daxxify as alternative of botox for smoothing facial wrinkles Dr. Kamal Kant Kohli15 Sept 2022 8:00 PM ISTThe U.S. Food and Drug Administration (FDA) has approved Daxxify, a new injectable medicine for smoothing facial wrinkles among adults. Daxxify is...
